Peritonitis in the baboon: A primate model which simulates human sepsis

Shock

Volumn 13, Issue 2, 2000, Pages 100-109

  Kinasewitz, Gary T ^a,c   Chang, Alvin C K ^b   Peer, Glenn T ^a   Hinshaw, Lerner B ^c   Taylor Jr , Fletcher B ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c WP 1310 ^*

Author keywords

Cytokines; E. coli; Hemodynamics; Hemostasis; Inflammation; Sepsis

Indexed keywords

INTERLEUKIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLOOD; DISEASE MODEL; ENTEROBACTER INFECTION; FEMALE; HEMODYNAMICS; HEMOSTASIS; INFLAMMATION; KIDNEY; LIVER; LUNG; MALE; METABOLISM; MICROBIOLOGY; PAPIO; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM; PERITONITIS; PHYSIOLOGY; SEPSIS;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMODYNAMIC PROCESSES; HEMOSTASIS; INFLAMMATION; INTERLEUKINS; KIDNEY; LIVER; LUNG; MALE; PAPIO; PERITONEUM; PERITONITIS; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034134085     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-200013020-00003     Document Type: Article

References (44)

1. Bone RC, Fisher CJ, Clemmer TP: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653-658, 1987.
2. Hinshaw LB, Veterans Administration Study Group: Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659-665, 1987.
3. Aube H, Milan C, Blettery B: Risk factors for septic shock in the early management of bacteremia. Am J Med 93:283-288, 1992.
4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. J Am Med Assoc 273:117-123, 1995.
5. Brun-Buisson C, Doyon F, Carlet J: Bacteremia and severe sepsis in adults: a multicenter prospective study in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 154:617-624, 1996.
6. Ziegler EJ, Fisher CJ, Sprung CL, et al.: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N Engl J Med 324:429-436, 1991.
7. Abraham E, Wunderink R, Silverman H, et al.: Efficacy and safety of monoclonal antibody to human tumor necrosis factor a in patients with sepsis syndrome. J Am Med Assoc 273:934-941, 1995.
8. Fisher CJ Jr. Agosti JM, Opal SM, et al.: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N Engl J Med 334: 1697-1702, 1996.
9. Bernard GR, Wheeler AP, Russell JA, et al.: The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 336: 912-918, 1997.
10. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock - a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
11. Fink MP, Heard SO: Laboratory models of sepsis and septic shock. J Surg Res 49:186-196, 1990.
12. Deitch EA: Animal models of sepsis and shock: a review and lessons learned. Shock 9:1-11, 1998.
13. Redl H, Schlag G, Bahrami S: Letter to editor: Animal models of sepsis and shock: a review and lessons learned. Shock 10:442-445, 1998.
14. Hinshaw LB, Brackett DJ, Archer LT, Beller BK, Wilson MF: Detection of the "hyperdynamic state" of sepsis in the baboon during lethal E. coli infusion. J Trauma 23:361-365, 1983.
15. Hinshaw LB, Emerson TE Jr, Taylor FB Jr, et al.: Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma 33:568-573, 1992.
16. 100 septic shock following therapy with antibody to tumor necrosis factor (TNFα). Circ Shock 30:279-292, 1990.
17. Welty-Wolf KE, Carraway MS, Huang Y-CT, Simonson SG, Kantrow SP, Piantados CA: Bacterial priming increases lung injury in gram-negative sepsis. Am J Respir Crit Care Med 158:610-619, 1998.
18. Fischer E, Marano MA, Van Zee KJ, et al.: Interleukin-1 receptor block7 ade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 89:1551-1557, 1992.
19. Redl H, Schlag G, Bahrami S, et al.: Influence of TNF antibody treatment on mediator release in baboon bacteremia/endotoxemia. In Levin J, Alving CR, Munford RS, Stutz PL (eds): Bacterial Endotoxin: Recognition and Effector Mechanisms. New York, NY: Elsevier Science Publishers B.V., 1993, pp 433-441.
20. Taylor FB Jr, Esmon CT, Hinshaw LB: Summary of staging mechanism and intervention studies in the baboon model of E. coli sepsis. J Trauma 30:S197-S203, 1990.
21. Bone RC, Grodzin CJ, Balk RA: Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235-243, 1997.
22. Wheeler AP, Bernard GR: Treating patients with severe sepsis. N Engl J Med 340:207-214, 1999.
23. Ahrenholz D, Simmons R: Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery 88:41-47, 1980.
24. Nakatani T, Sato T, Marzella L, Hirai F, Trump BF, Siegel JH: Hepatic and systemic metabolic responses to aerobic and anaerobic intraabdominal abscesses in a highly reproducible chronic rat model. Circ Shock 13:271-294, 1984.
25. Alexander JW, Gonce SJ, Miskell PW, Peck MD, Sax H: A new model for studying nutrition in peritonitis: the adverse effect of overfeeding. Ann Surg 209:334-340, 1989.
26. Lang CH, Bagby GJ, Bornside GH, Vial LJ, Spitzer JJ: Sustained hypermetabolic sepsis in rats: characterization of the model. J Surg Res 35:204-210, 1983.
27. Novo C, Ais G, López-Farré A, Romeo J, Pérez-Barriocanal F, López-Novoa JM: Factors associated with hyperdynamic or hypodynamic circulation and role of platelet-activating factor in hemodynamic alterations in bacterial peritonitis in conscious rats. J Cardiovasc Pharmacol 26:937-942, 1995.
28. Fink MP, MacVittie TJ, Casey LC: Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg 200:619-626, 1984.
29. Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE: Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 78:259-270, 1986.
30. Goldfarb RD, Glock D, Kumar A, et al.: A porcine model of peritonitis and bacteremia simulates human septic shock. Shock 6:442-451, 1996.
31. Gretch DR, Suter M, Stinsky MF: The use of biotinylated monoclonal antibodies and streptavidin affinity chromatography to isolate herpes virus. Anal Biochem 163:270-277, 1987.
32. 100 E. coli. Blood 91:1609-1615, 1998.
33. Taylor FB Jr, He SE, Chang ACK, et al.: Infusion of phospholipid vesicles amplifies the local thrombotic response to TNF (tumor necrosis factor) and anti-protein C into a consumptive response. Thromb Haemost 75:578-584, 1996.
34. 2+-dependent monoclonal antibody with the protein C activation peptide region. J Biol Chem 263:826-832, 1988.
35. de Boer JP, Creasy AA, Chang A, et al.: Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock 39:59-67, 1993.
36. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874, 1992.
37. Brun-Buisson C, Doyon F, Carlet J, et al.: Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. J Am Med Assoc 274:968-974, 1995.
38. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with sepsis syndrome. Ann Intern Med 119:771-778, 1993.
39. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 320:1165-1172, 1989.
40. Wada H, Minamikawa K, Wakita Y, et al.: Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol 43:190-194, 1993.
41. Vervloet MG, Thijs LG, Hack CE: Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Hemost 24:33-44, 1998.
42. Krausz MM, Perel A, Eimerl D, Cotev S: Cardiopulmonary effects of volume loading in patients in septic shock. Ann Surg 185:429-434, 1977.
43. Bryant RE, Hood AF, Hood CE, Koenig MG: Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 127:120-128, 1971.
44. Shenep JL, Flynn PM, Barrett FF, Stidham GL, Westenkirchner DF: Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis. J Infect Dis 157:565-568, 1988.